期刊文献+

蛋白酶活化受体-1在鼻咽癌中的表达及意义 被引量:3

Expression of Protease-Activated Receptor-1 in Nasopharyngeal Carcinoma and Its Significance
下载PDF
导出
摘要 目的检测PAR1在鼻咽癌中的表达,探讨PAR1在鼻咽癌中表达的意义。方法免疫组织化学(SP法)检测28例良性鼻咽组织、61例鼻咽癌组织中PAR1中的表达;采用RT-PCR、Western Blot检测鼻咽癌细胞系CNE-1、CNE-2中PAR1表达并比较其表达差异。结果PAR1在鼻咽癌组织及两种鼻咽癌细胞株中均表达。PAR1在28例良性鼻咽组织表达为10例,61例鼻咽癌组织中表达48例。PAR1在鼻咽癌组织中的表达率明显高于在良性鼻咽组织中的表达率(P<0.01),高度恶性细胞株中PAR1的表达明显高于其低度恶性细胞株。结论PAR1的表达与鼻咽癌的发生、生长方式、分期、恶性程度等有关。PAR1在鼻咽癌中的表达可能介导鼻咽癌侵袭转移等恶性生物学行为。 Objective To investigate the expression of PAR1 in nasopharyngeal carcinoma (NPC)and its significance. Methods Immunohistochemical(SP method)was used to detect PAR1 expression in 28 cases of benign nasopharyngeal tissues and 61 cases of NPC. The relationship between the expression of PAR1 in NPC and the clinical parameters was retrospectively analyzed. Receptor expression on protein and mRNA level was evaluated in two human NPC cell lines (CNE-2 and CNE-1) by Western Blot, and RT-PCR. Results Of 61 cases of NPC examined, PAR1 expresses in 48 cases; of 28 cases of nasopharyngeal benign lesions examined, PAR1 expressed in 10 cases. The rate of PAR1 expressed in NPC was higher than that in the nasopharyngeal benign lesions (P〈0. 01 ). The more malignant and metastasis cell line(CNE-2)expressed higher mRNA and protein level of PAR1 than the lowly malignant and metastasis cell line(CNE-1)by RT-PCR and Western Blot. Conclusion The expression of PAR1 is correlated with carcinogenesis, growth pattern, clinical staging, malignancy of NPC. PAR1 may contribute to the malignant phenotype and biological behavior in NPC.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2008年第2期100-103,共4页 Cancer Research on Prevention and Treatment
关键词 鼻咽癌 蛋白酶活化受体-1 转移 Nasopharyngeal carcinoma Protease-activated receptor-1 Metastasis
  • 相关文献

参考文献12

  • 1Shanmugaratnam K, Sobin LH. Histological typing of tumors of the upper respiratory tract and ear[M]. 2nd Ed. Berlin: Springer-Verlag, 1991.32-33.
  • 2Even-Ram S, Uziely B, Cohen P, et al. Thrombin receptor overexpression in malignant and physiological invasion processes[J]. Nat Med, 1998,4(8) :909-914.
  • 3Martin CB,Mahon GM, Klinger MB, et al. The thrombin receptor,PAR1 ,causes transformation by activation of Rho-mediated signaling pathways[J]. Oncogene, 2001,20 (16) : 1953- 1963.
  • 4Turcotte S,Desrosiers RR,Brand G,et al. Von Hippel-Lindau tumor suppressor protein stimulation by throrobin involves RhoA activation[J]. Int J Cancer,2004,112(5) :777-786.
  • 5Boire A,Covic L,Agarwal A,et al. PAR1 is a matrix metalloprotease- 1 receptor that promotes invasion and tumorigenesis of breast cancer cells[J]. Cell,2005,120(3) :303-313.
  • 6Even-Ram SC,Maoz M, Pokroy E,et al. Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with t he alpha v beta 5 integrin[J]. J Biol Chem, 2001,276(14):10952-10962.
  • 7Liu J, Schuff-Werner P, Steiner M. Thrombin/thrombin receptor (PAR-1)- mediated induction of IL-8 and VEGF expression in prostate cancer cells[J]. Biochem Biophy Res Commun 2006,343 (1) : 183-189.
  • 8Yin YJ, Salah Z, Maoz M, et al. Oncogenic transformation induces tumor angiogenesis : a role for PAR1 activation[J]. FASEB J, 2003,17 (2) : 163-174.
  • 9Yin YJ,Katz V, Salah Z, et al. Mammary Gland Tissue Targeted Overexpression of Human Protease-Activated Receptor 1 Reveals a Novel Link to B-Catenin Stabilization[J]. Cancer Res, 2006,66(10):5224-5233.
  • 10Zhang X, Hunt JL, Chen Z, et al. Correlation of Protease-Activated Receptor-1 With Differentiation Markers in Squamous Cell Carcinoma of the Head and Neck and Its Implication in Lymph Node Metastasis[J]. Clinical Cancer Research, 2004, 10(24) : 8451-8459.

同被引文献50

  • 1孟宇宏,虞积耀,张金强,路平,宁浩勇,胡明,陆应麟.蛋白酶激活受体-1促进肺癌细胞侵袭和转移功能的研究[J].中华病理学杂志,2007,36(5):313-317. 被引量:5
  • 2Liu J, Schuff Werner P. Steiner M. Double transfection improves small interfering RNA induced thrombin receptor ( PAR1 ) gene silencing in DU 145 prostate cancer cells[J]. FEBS Lett, 200,1, 577 (122): 175-180.
  • 3Martin C B, Mahon G M. Klinger M B, et al. The thrombin receptor,PAR1 ,causes transformation by activation of Rho-mediated signaling pathways[J]. Oncogene, 2001, 20(16): 1953- 1963.
  • 4Feist ritzer C .Riewald M. Endothelial barrier protection by ac tivated protein C through PAR1 dependent sphingosine-1- phosphate receptor-1 cross activation[J].Blond, 2005, 105(8):3178-3184.
  • 5Huang Y Q, Li J J. Hu I., et al. Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes[J].Thromb Haemost. 2001, 86(4): 1094-1098.
  • 6Yin Y J, Salah Z, Maoz M, et al. Oncogenic transformation induces tumor angiogenesis:a role for PAR1 activation[J]. FASEB J, 2003, 17(2): 163-174.
  • 7Boire A, Covic L. Agarwal A, et al. PAR1 is a matrix metallo prntease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells[J]. Cell. 2005, 120(3): 303-313.
  • 8Lu J, Chua H H, ChenSY,et al. Regulation of matrixmetallo proteinase-1 by epstein barr virus proteins[J]. Cancer Res, 2003.63(1) :256-262.
  • 9VU T K, HUNG D T, WHEATON V 1, et aL Molecular cloning of a functional thrombin receptor reveals a novel pro- teolytic mechanism of receptor activation [J]. Cell, 1991, 64(6): 1057-1068.
  • 10KULIOPULOS A, COVIC L, SEELEY S K, et at. Plasmin de- sensitization of the PARI thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy[J]. Bioch- emistry, 1999, 38(14): 4572-4585.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部